Results 41 to 50 of about 44,903 (210)

Hand-assisted laparoscopic splenectomy

open access: yes, 2000
Laparoscopic splenectomy is performed routinely in patients with small and moderately enlarged spleens at specialized centers. Large spleens are difficult to handle laparoscopically and hand-assisted laparoscopic splenectomy might facilitate the ...
Gouma, D. J.   +3 more
core   +1 more source

Laparoscopic splenectomy for Evans syndrome

open access: yes, 2003
Evans syndrome is a rare, chronic, sometimes fatal immunologic disorder defined as Coombs\u27 positive hemolytic anemia and immune thrombocytopenia without an underlying etiology.
Brody, Fred   +2 more
core   +1 more source

Splenectomy for hematological disorders [PDF]

open access: yes, 2014
Splenectomy is therapeutic for a large host of conditions. It is a consequence of expanding the list of disorders and liberalizing the indications for splenectomy in many diseases.
Jankulovski, Nikola   +3 more
core  

Splenectomy in epithelial ovarian cancer surgery

open access: yes, 2023
International audienceObjective Splenectomy is performed in 4–32% of cytoreductive surgeries for ovarian cancer. The objective of our study was to assess splenectomy and evaluate its impact on overall and disease-free survival.
Frederic Beurrier   +13 more
core   +1 more source

Robotic Splenectomy

open access: yes, 2011
While laparoscopic splenectomy has become the standard procedure for the surgical treatment of hematologic splenic disorders, the role of robotic splenectomy is still a matter of debate.
Catalin Vasilescu
core   +1 more source

Red blood cell membrane proteome as a reporter of disease severity, transfusion impact and genetic background in transfusion‐dependent β‐thalassaemia

open access: yesBritish Journal of Haematology, EarlyView.
Summary Omics technologies have transformed research in haemoglobinopathies, yet the proteome of RBCs remains largely unexplored in transfusion‐dependent thalassaemia (TDT). In this proteomic analysis, Red blood cell (RBC) membranes from 48 adults with TDT were compared with healthy controls.
Konstantina Theocharaki   +8 more
wiley   +1 more source

Laparoscopic splenectomy: postero-lateral approach [PDF]

open access: yes, 2019
In paediatric population, the laparoscopic splenectomy has been preferred to the open surgery during the last years. Due to the improvement of the technique and the devices, the indications to the laparoscopic splenectomy have been increased, even though
Garzi, Alfredo   +4 more
core   +1 more source

MicroRNAs as potential architects of immune dysregulation and megakaryocytic failure in immune thrombocytopenia

open access: yesBritish Journal of Haematology, EarlyView.
Summary Immune thrombocytopenia (ITP) is a complex autoimmune disorder characterized by accelerated destruction of peripheral platelets and impaired megakaryopoiesis. While the cellular effectors, dysregulated T cells, hyperactive B cells and phagocytic macrophages are well characterized, the upstream epigenetic mechanisms orchestrating this ...
Zhenyu Liu   +8 more
wiley   +1 more source

Laparoscopic splenectomy in children.

open access: yes, 2005
BACKGROUND: Laparoscopic splenectomy is being performed more commonly in children, although its advantages are not clear. We sought to determine whether laparoscopic splenectomy was superior to open splenectomy.
Kane, Timothy D.   +12 more
core   +1 more source

Real‐world treatment patterns and outcomes among patients with immune thrombocytopenia (ITP) who switched treatment from eltrombopag or romiplostim to avatrombopag in the United States: Results from the REAL‐AVA 3.5 study

open access: yesBritish Journal of Haematology, EarlyView.
Summary Real‐world data on treatment response after switching between thrombopoietin receptor agonists are limited for patients with immune thrombocytopenia (ITP). The objective of this study is to describe treatment patterns and outcomes in patients with primary ITP who switched from eltrombopag (ELT) or romiplostim (ROMI) to avatrombopag (AVA).
Caroline Piatek   +8 more
wiley   +1 more source

Home - About - Disclaimer - Privacy